Guillain‐Barré syndrome following COVID‐19 vaccination: An updated systematic review of cases
<h3>Key Clinical Message</h3><p dir="ltr">Guillain‐Barré syndrome (GBS) is a rare but possible complication that may occur after COVID‐19 vaccination. In this systematic review, we found that GBS presented in patients with an average age of 58. The average time for sympto...
Saved in:
| Main Author: | Nour Shaheen (14034758) (author) |
|---|---|
| Other Authors: | Abdelraouf Ramadan (17687433) (author), Abdulqadir J. Nashwan (11659453) (author), Ahmed Shaheen (15205087) (author), Shahzaib Ahmad (16676910) (author), Karam R. Motawea (13954362) (author), Salaheldin Mohamed (21397952) (author), Rahma Sameh Mohamed (21397955) (author), Sarya Swed (12331238) (author), Hani Aiash (12324223) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar
by: Almurtada Razok (12204854)
Published: (2021) -
COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series
by: Abdel-Naser Elzouki (9376853)
Published: (2021) -
Atypical Guillain–Barre syndrome with T6 sensory level
by: Osamah Al‐Ameen (21383678)
Published: (2022) -
Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report
by: Hussam Al Soub (17269024)
Published: (2021) -
COVID-19Base v3: Update of the knowledgebase for drugs and biomedical entities linked to COVID-19
by: Syed Abdullah Basit (18021787)
Published: (2023)